All Comments by Henrik Zetterberg
Go to another page:
- 1
- 2
- Could Blood Transfusions Transmit Vascular Amyloid?
- Alzheimer’s, Primary Age-Related Tauopathy Take Separate Paths
- Treatment for Lysosomal Storage Disorder Lowers NfL
- Neuronal Pentraxin 2 Binds Complement Protein, Protects Synapses
- Finally, a Biomarker to Distinguish Primary Tauopathies?
- Blood Metabolome Predicts 23 Diseases, Including Dementia
- John Trojanowski, 75, a Giant in the Field of Neuropathology
- Exposure, Exposure, Exposure? At CTAD, Aducanumab Scientists Make a Case
- ‘Reports of My Death Are Greatly Exaggerated.’ Signed, Aducanumab
- Closing in on a Blood Test for Alzheimer’s?
- At Risk, or Already Alzheimer’s? Elevated Aβ Predicts Cognitive Decline
- Blood Neurofilament Light a Promising Biomarker for Alzheimer’s?
- Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.
- Lessons from a failed γ-secretase Alzheimer trial.
- GSAP Revisited: Does It Really Play a Role in Processing Aβ?